LOGIN
Subcutaneous Teriparatide for Pelvic Fracture Healing: A Phase 2 Randomized Controlled Trial
February 2022
Subcutaneous Teriparatide for Pelvic Fracture Healing: A Phase 2 Randomized Controlled Trial
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Teriparatide and pelvic fracture healing: a phase 2 randomized controlled trial.
Osteoporos Int. 2022 Jan;33(1): 239-250.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Thirty-five patients over the age of 50 with an acute pelvic fracture were randomized to receive 3 months of subcutaneous teriparatide injections (n=18) or placebo injections (n=17). Outcomes of interest included pain scores on a Numeric Rating Scale (NRS), physical performance scores (Continuous Summary Physical Performance Score [CSPPS]; timed up and go), and bone healing. Results revealed no si...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.